Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Chongkundang Holdings Corp

+ Add to Watchlist

001630:KS

93,500 KRW 3,500 3.61%

As of 02:14:42 ET on 05/29/2015.

Snapshot for Chongkundang Holdings Corp (001630)

Open: 97,100 Day's Range: 93,000 - 98,800 Volume: 43,405
Previous Close: 97,000 52wk Range: 41,700 - 101,000 1-Yr Rtn: +103.20%

Stock Chart for 001630

No chart data available.
  • 001630:KS 93,500
  • 1D
  • 1M
  • 1Y
97,000
Interactive 001630 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 001630

Current P/E Ratio (ttm) 74.1475
Estimated P/E(12/2015) -
Relative P/E vs. KOSPI 4.0292
Earnings Per Share (KRW) (ttm) 1,261.0000
Est. EPS (KRW) (12/2015) -
Est. PEG Ratio -
Market Cap (M KRW) 418,671.12
Shares Outstanding (M) 4.48
30 Day Average Volume 36,901
Price/Book (mrq) 1.9276
Price/Sale (ttm) 1.7201
Dividend Indicated Gross Yield 0.75%
Cash Dividend (KRW) 700.0000
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth -11.01%
Next Earnings Announcement 08/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 001630

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 001630

Chongkundang Holdings Corporation operates as a holding company. The Company, through its subsidiaries, manufactures pharmaceutical products and medical drugs in the fields of systemic anti-infective, cardiovascular system, alimentary tract, metabolism, and sensory organs.

Rhee Jang-HanChairmanKim Jung-WooVice Chairman/CEO/Rep Director
Kim Tae-YeongSenior Managing DirectorHan Sung-WookManaging Director
More Company Profile & Key Executives for 001630

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil